​

Funding Round

Series A - Juvena Therapeutics

Series A - Juvena Therapeutics

Investment Firm

Overview

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

Announced Date

Nov 08, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Horizons Ventures

Horizons Ventures

Horizons Ventures is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Mubadala Capital Ventures

Mubadala Capital Ventures

Mubadala Capital Ventures is a early_stage_venture and late_stage_venture and post_ipo firm.

Participant Investors

11

Investor Name
Participant InvestorJeff Dean
Participant InvestorIntersect VC
Participant InvestorHorizons Ventures
Participant InvestorCompound
Participant InvestorFelicis

Round Details and Background

Juvena Therapeutics raised $41000000 on 2022-11-08 in Series A

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2021
Non Equity Assistance - Juvena Therapeutics
1-undefined
Nov 23, 2021
Grant - Juvena Therapeutics
1-3.9M
Oct 01, 2021
Convertible Note - Juvena Therapeutics
1-undefined
Nov 08, 2022
Series A - Juvena Therapeutics
13-41.0M

Recent Activity

There is no recent news or activity for this profile.